Researchers from Prof. Karl Deisseroth's laboratory have developed techniques for specifically modulating the activity of excitable cells in vivo. This approach introduces light-responsive proteins to create photo-sensitive cells. Then fiber optic technology activates these proteins deep within tissues. The general methods can be used to selectively either stimulate or inhibit a variety of cells, including neurons, heart, and muscle cells, even when the target cells are embedded within a community of other cells.
This technology relies on numerous small light sources, in different positions and pointed in different directions to provide multiple sources of cellular control within one device. Because this invention offers a privileged channel of communication with specific cells, it offers precise control with less side effects on non-targeted cell populations.
Stage of Research:The inventors have developed a prototype device for testing this approach in vivo.
Related Technologies:The Deisseroth lab has identified a variety of rhodopsin-like proteins that can be used in neuromodulation. These are described in Stanford Dockets
S05-170,
S06-398,
S08-105 and
S08-348.
